Par Pharmaceutical Companies
Part of Endo Pharmaceuticals
Is this your company?
Find the right fit for you - faster
Get tailored insights about working at Par Pharmaceutical Companies in one quick step.
Par Pharmaceutical Companies Snapshot
Generic drugs are par for the course for Par Pharmaceutical Companies (Par). The company markets about 50 generic drugs in some 175 dosages; its generic product line focuses on central nervous system, cardiovascular, and anti-inflammatory medications, as well as infectious disease. The generic division manufactures some of its own products, but it also distributes drugs manufactured by strategic partners. The company is moving into the branded pharmaceutical market as well by developing updated versions of off-patent drugs through its Strativa division. Par markets product through its internal sales force, mainly to wholesalers, retail pharmacy chains, and managed care organizations across the US.
